Radko Avi

568 total citations
29 papers, 244 citations indexed

About

Radko Avi is a scholar working on Virology, Infectious Diseases and Epidemiology. According to data from OpenAlex, Radko Avi has authored 29 papers receiving a total of 244 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Virology, 20 papers in Infectious Diseases and 15 papers in Epidemiology. Recurrent topics in Radko Avi's work include HIV Research and Treatment (23 papers), HIV/AIDS drug development and treatment (14 papers) and Hepatitis C virus research (12 papers). Radko Avi is often cited by papers focused on HIV Research and Treatment (23 papers), HIV/AIDS drug development and treatment (14 papers) and Hepatitis C virus research (12 papers). Radko Avi collaborates with scholars based in Estonia, United States and United Kingdom. Radko Avi's co-authors include Kristi Huik, Irja Lutsar, Anneli Uusküla, Don Des Jarlais, Jack DeHovitz, Kaja-Triin Laisaar, Katri Abel‐Ollo, Ave Talu, Kristi Rüütel and Matti Maimets and has published in prestigious journals such as PLoS ONE, The Journal of Infectious Diseases and JAIDS Journal of Acquired Immune Deficiency Syndromes.

In The Last Decade

Radko Avi

27 papers receiving 238 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Radko Avi Estonia 10 137 132 117 58 52 29 244
Manuel Gómez Carrillo Argentina 7 215 1.6× 177 1.3× 102 0.9× 57 1.0× 29 0.6× 9 275
James Brandful Ghana 9 77 0.6× 75 0.6× 106 0.9× 69 1.2× 22 0.4× 10 203
Benjamin Silbermann France 6 76 0.6× 82 0.6× 104 0.9× 63 1.1× 25 0.5× 8 182
María Belén Bouzas Argentina 10 126 0.9× 143 1.1× 140 1.2× 101 1.7× 64 1.2× 34 313
Jean Pierre Routy Canada 6 211 1.5× 186 1.4× 66 0.6× 31 0.5× 38 0.7× 9 268
Michael Mirabile United States 4 184 1.3× 106 0.8× 115 1.0× 87 1.5× 64 1.2× 4 259
Vasudha Sundaravaradan United States 12 239 1.7× 138 1.0× 81 0.7× 16 0.3× 138 2.7× 16 297
Pieter Jooste South Africa 9 89 0.6× 89 0.7× 132 1.1× 84 1.4× 61 1.2× 12 249
Makiko Kondo Japan 10 220 1.6× 218 1.7× 73 0.6× 30 0.5× 15 0.3× 30 280
А В Кравченко Russia 10 309 2.3× 263 2.0× 191 1.6× 67 1.2× 11 0.2× 35 381

Countries citing papers authored by Radko Avi

Since Specialization
Citations

This map shows the geographic impact of Radko Avi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Radko Avi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Radko Avi more than expected).

Fields of papers citing papers by Radko Avi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Radko Avi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Radko Avi. The network helps show where Radko Avi may publish in the future.

Co-authorship network of co-authors of Radko Avi

This figure shows the co-authorship network connecting the top 25 collaborators of Radko Avi. A scholar is included among the top collaborators of Radko Avi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Radko Avi. Radko Avi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Soeorg, Hiie, Kati Hensen, Kristi Rüütel, et al.. (2025). Transmitted HIV-1 drug resistance in Estonian residents and Ukrainian refugees in 2020 and 2022. Journal of Global Antimicrobial Resistance. 41. 258–265.
2.
Soeorg, Hiie, Aare Abroi, Paul Naaber, et al.. (2024). Dynamics of SARS-CoV-2 lineages in children and adults in 2021 and 2022. PLoS ONE. 19(12). e0316213–e0316213.
3.
Zilmer, Kai, et al.. (2023). No transmitted drug resistance to HIV integrase strand-transfer inhibitors after their scale-up in Estonia in 2017. Journal of Global Antimicrobial Resistance. 33. 83–88. 2 indexed citations
4.
Avi, Radko, et al.. (2021). Dynamics of hepatitis C epidemic among people living with HIV in Estonia based on Estonian HIV cohort study. BMC Infectious Diseases. 21(1). 792–792. 2 indexed citations
5.
Uusküla, Anneli, Peter Vickerman, Mait Raag, et al.. (2020). Presenting a conceptual framework for an HIV prevention and care continuum and assessing the feasibility of empirical measurement in Estonia: A case study. PLoS ONE. 15(10). e0240224–e0240224. 2 indexed citations
6.
Huik, Kristi, S. Michele Owen, Wei Luo, et al.. (2019). The concordance of the limiting antigen and the Bio-Rad avidity assays in persons from Estonia infected mainly with HIV-1 CRF06_cpx. PLoS ONE. 14(5). e0217048–e0217048. 3 indexed citations
7.
Simmons, Ruth, Kristi Huik, Matti Maimets, et al.. (2017). HIV incidence in the Estonian population in 2013 determined using the HIV‐1 limiting antigen avidity assay. HIV Medicine. 19(1). 33–41. 14 indexed citations
8.
Huik, Kristi, Silver Türk, Don C. Des Jarlais, et al.. (2016). T Cell Distribution in Relation to HIV/HBV/HCV Coinfections and Intravenous Drug Use. Viral Immunology. 29(8). 464–470. 7 indexed citations
9.
Avi, Radko, et al.. (2016). Human T-lymphotropic virus types 1 and 2 are rare among intravenous drug users in Eastern Europe. Infection Genetics and Evolution. 43. 83–85. 7 indexed citations
10.
Huik, Kristi, Radko Avi, Kristi Rüütel, et al.. (2016). A CCL5 Haplotype Is Associated with Low Seropositivity Rate of HCV Infection in People Who Inject Drugs. PLoS ONE. 11(6). e0156850–e0156850. 3 indexed citations
11.
Huik, Kristi, Silver Türk, Don Des Jarlais, et al.. (2015). Differences in T cell distribution and CCR5 expression in HIV-positive and HIV-exposed seronegative persons who inject drugs. Medical Microbiology and Immunology. 205(3). 231–239. 7 indexed citations
12.
Avi, Radko, et al.. (2015). Design and structure of the Estonian HIV Cohort Study (E-HIV). Infectious Diseases. 47(11). 768–775. 9 indexed citations
13.
Huik, Kristi, et al.. (2014). Influence of interleukin 10 polymorphisms -592 and -1082 to the HIV, HBV and HCV serostatus among intravenous drug users. Infection Genetics and Evolution. 30. 175–180. 12 indexed citations
14.
Avi, Radko, et al.. (2013). Transmitted Drug Resistance Is Still Low in Newly Diagnosed Human Immunodeficiency Virus Type 1 CRF06_cpx-Infected Patients in Estonia in 2010. AIDS Research and Human Retroviruses. 30(3). 278–283. 10 indexed citations
15.
Huik, Kristi, et al.. (2013). Association between TLR3 rs3775291 and resistance to HIV among highly exposed Caucasian intravenous drug users. Infection Genetics and Evolution. 20. 78–82. 33 indexed citations
16.
Avi, Radko, et al.. (2010). Characterization of Integrase Region Polymorphisms in HIV Type 1 CRF06_cpx Viruses in Treatment-Naive Patients in Estonia. AIDS Research and Human Retroviruses. 26(10). 1109–1113. 9 indexed citations
17.
Laisaar, Kaja-Triin, Radko Avi, Jack DeHovitz, & Anneli Uusküla. (2010). Estonia at the Threshold of the Fourth Decade of the AIDS Era in Europe. AIDS Research and Human Retroviruses. 27(8). 841–851. 23 indexed citations
18.
Huik, Kristi, Radko Avi, Kristi Rüütel, et al.. (2010). CCL3L1Copy Number Is a Strong Genetic Determinant of HIV Seropositivity in Caucasian Intravenous Drug Users. The Journal of Infectious Diseases. 201(5). 730–739. 25 indexed citations
19.
Avi, Radko, et al.. (2010). Emerging transmitted drug resistance in treatment-naïve human immunodeficiency virus-1 CRF06_cpx-infected patients in Estonia. Scandinavian Journal of Infectious Diseases. 43(2). 122–128. 13 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Manuel Gómez Carrillo Breakdown of academic impact, for papers by James Brandful Breakdown of academic impact, for papers by Benjamin Silbermann Breakdown of academic impact, for papers by María Belén Bouzas Breakdown of academic impact, for papers by Jean Pierre Routy Breakdown of academic impact, for papers by Michael Mirabile Breakdown of academic impact, for papers by Vasudha Sundaravaradan Breakdown of academic impact, for papers by Pieter Jooste Breakdown of academic impact, for papers by Makiko Kondo Breakdown of academic impact, for papers by А В Кравченко
Rankless by CCL
2026